Home › NDC Lookup › RxCUI directory › RxCUI 1045456

2 ML eribulin mesylate 0.5 MG/ML Injection — RxCUI 1045456

RxNorm drug concept · Semantic clinical drug
RxCUI 1045456 Semantic clinical drug · SCD ● Current RxNorm concept 17 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1045456
Official name2 ML eribulin mesylate 0.5 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aseribulin mesylate 1 MG per 2 ML Injection; eriBULin mesylate 1 MG in 2 ML Injection
FDA products mapped17
Package NDCs mapped17
Reported Medicaid activity (SDUD)1,351 prescriptions · 24 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Eribulin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Eribulin (brand name Halaven) is approved for two specific cancers: metastatic breast cancer and a type of soft tissue cancer called liposarcoma. For breast cancer, it's used after...
  • What exactly is eribulin used for — and is it right for my type of cancer?
  • No, you won't need daily visits. Eribulin is given as a quick IV infusion — usually just 2 to 5 minutes — directly into a vein by your care team. You receive it on Day 1 and Day 8...
  • How is eribulin given, and will I have to go to a clinic every day?
📖 Read our full Eribulin Injection guide →

🕸️ Concept Web — How 2 ML eribulin mesylate 0.5 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 2 ML eribulin mesylate 0.5 MG/ML Injection RxCUI 1045456

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Eribulin 1045453
    • Eribulin mesylate 1045452
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Halaven 1045457
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Eribulin Injection 1736560
    • Eribulin mesylate Injection 2645583
    • Eribulin Injectable Product 1162502
    • Eribulin mesylate Injectable Product 2662044
    • Eribulin Injection [Halaven] 1736562
    • Eribulin mesylate Injection [Halaven] 2658605
    • Halaven Injectable Product 1176093
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Eribulin mesylate 0.5 MG/ML SCDC · 1045454
  • Eribulin Injection SCDF · 1736560
  • Eribulin mesylate Injection SCDFP · 2645583
  • Eribulin Injectable Product SCDG · 1162502
  • Eribulin mesylate Injectable Product SCDGP · 2662044

Brand-Name Concepts

  • 2 ML eribulin mesylate 0.5 MG/ML Injection [Halaven] SBD · 1045460
  • Eribulin mesylate 0.5 MG/ML [Halaven] SBDC · 1045458
  • Eribulin Injection [Halaven] SBDF · 1736562
  • Eribulin mesylate Injection [Halaven] SBDFP · 2658605
  • Halaven Injectable Product SBDG · 1176093
  • Halaven BN · 1045457

📦 FDA Products & Package NDCs

17 products · 17 package NDCs
17 package NDCs map to RxCUI 1045456 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9167-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0143-9167-01) / 2 mL in 1... ERIBULIN MESYLATE HIKMA PHARMACEUTICALS USA INC. 2024-06-28
00781-3391-94 1 VIAL in 1 CARTON (0781-3391-94) / 2 mL in 1 VIAL Eribulin Mesylate Sandoz Inc 2025-07-07
10019-0080-01 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1... Eribulin Mesylate Baxter Healthcare Company 2024-12-01
39822-2080-01 1 VIAL, SINGLE-DOSE in 1 CARTON (39822-2080-1) / 2 mL in 1... ERIBULIN MESYLATE XGen Pharmaceuticals DJB, Inc. 2026-04-07
40033-0364-01 1 VIAL, SINGLE-DOSE in 1 CARTON (40033-364-01) / 2 mL in 1... ERIBULIN MESYLATE Kindos Pharmaceuticals Co., Ltd. 2025-08-05
43598-0125-11 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-125-11) / 2 mL in 1... Eribulin Mesylate Dr. Reddys Laboratories Inc 2026-01-22
43624-0002-01 100 VIAL in 1 TRAY (43624-002-01) / 2 mL in 1 VIAL Halaven BSP Pharmaceuticals SpA 2017-04-21
60505-6289-00 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6289-0) / 2 mL in 1... eribulin mesylate Apotex Corp. 2024-05-06
60505-6435-00 1 VIAL, SINGLE-DOSE in 1 CARTON (60505-6435-0) / 2 mL in 1... eribulin mesylate Apotex Corp. 2025-03-19
62856-0389-01 1 VIAL, SINGLE-DOSE in 1 CARTON (62856-389-01) / 2 mL in 1... Halaven Eisai Inc. 2010-11-15
68001-0656-41 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-656-41) / 2 mL in 1... Eribulin Mesylate BluePoint Laboratories 2025-10-08
68083-0592-01 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-592-01) / 2 mL in 1... eribulin mesylate Gland Pharma Limited 2024-04-05
68462-0770-20 1 VIAL, SINGLE-DOSE in 1 CARTON (68462-770-20) / 2 mL in 1... ERIBULIN MESYLATE GLENMARK PHARMACEUTICALS INC., USA 2025-08-05
70095-0080-01 1 VIAL, SINGLE-DOSE in 1 CARTON (70095-080-01) / 2 mL in 1... ERIBULIN MESYLATE Sun Pharmaceutical Industries Limited 2025-05-15
71731-4171-01 1 VIAL, SINGLE-DOSE in 1 CARTON (71731-4171-1) / 2 mL in 1... Eribulin Mesylate Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2025-03-04
72603-0368-01 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-368-01) / 2 mL in 1... Eribulin Mesylate Northstar Rx LLC 2025-12-05
81298-3890-01 1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1... Eribulin Mesylate Long Grove Pharmaceuticals, LLC 2024-07-22
Observed labelers: Apotex Corp. (2) · Baxter Healthcare Company (1) · BluePoint Laboratories (1) · BSP Pharmaceuticals SpA (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Dr. Reddys Laboratories Inc (1) · +10 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9179 Eribulin mesylate injection 10 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.